Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Mild Cognitive Impairment Clinical Trials

29 recruiting trials for Mild Cognitive Impairment. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
29
Total Trials
29
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06664229

Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults

The goal of this intervention program is to test the effectiveness of pressure sensor based dementia and fall prevention program for improving cognitive and physical functions of...

Sponsor: Sunmi SongEnrolling: 2051 location
RECRUITINGPhase 3NCT07083154

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

The LIGHT-COG study is a 76-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial. A total of 420 type 2 diabetes patients with early...

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolEnrolling: 4208 locations
RECRUITINGNCT05372172

Tennessee Alzheimer's Project

The primary objective of the Vanderbilt Alzheimer's Disease Research Center (VADRC) is to provide local and national researchers with access to a well-characterized and diverse...

Sponsor: Vanderbilt University Medical CenterEnrolling: 10001 location
RECRUITINGNCT05748613

Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's

The goal of this clinical trial is to test the effectiveness of a computerized anxiety sensitivity treatment (CAST) compared to a health education control (HEC) in older adults...

Sponsor: Florida State UniversityEnrolling: 3883 locations
RECRUITINGNCT07154394

Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease

This study seeks to explore the possible common pathogenesis of both cardiac amyloidosis and Alzheimer's disease, which can both be associated with amyloid deposits. Using...

Sponsor: University Hospital, EssenEnrolling: 151 location
RECRUITINGNCT06793735

Effectiveness of TeleVR App in Cognitive Decline and MCI Patients

The goal of this clinical trial is to evaluate the effectiveness of a telerehabilitation program combined with a virtual reality (VR) app in improving cognitive performance and...

Sponsor: IRCCS Centro Neurolesi Bonino PulejoEnrolling: 4801 location
RECRUITINGNCT05929703

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care...

Sponsor: University of MichiganEnrolling: 19007 locations
RECRUITINGNCT05795634

Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

The goal of this clinical trial is to learn about how genetics and the response to stress predicts cognitive decline in individuals with mild cognitive impairment. The main...

Sponsor: Johns Hopkins UniversityEnrolling: 2401 location
RECRUITINGNCT03174938

The Swedish BioFINDER 2 Study

The Swedish BioFINDER 2 study is a new study that will launch in 2017 and extends the previous cohorts of BioFINDER 1 study (www.biofinder.se). BioFINDER 1 is used e.g. to...

Sponsor: Skane University HospitalEnrolling: 15052 locations
RECRUITINGNCT06448403

Multimodal Assesment of Alzheimer Patients

The goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD). The main questions the study...

Sponsor: Norwegian University of Science and TechnologyEnrolling: 601 location
RECRUITINGNCT05710549

Understanding Brain Mechanisms Involved in Autobiographical Memory

The overall objective of this project is to characterize the spatiotemporal dynamics of brain oscillations underpinning autobiographical memory (ABM) and the modulation of the...

Sponsor: Lucie BréchetEnrolling: 1201 location
RECRUITINGNCT07239310

Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and...

This study is a multicenter, randomized, double-blind, parallel-group, prospective confirmatory clinical trial designed to evaluate whether the Neuclare medical device can...

Sponsor: DeepsonbioEnrolling: 1383 locations
RECRUITINGNCT03954899

Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging

The study will examine whether 5mg melatonin (over the counter, OTC) over a 9-month period improves Alzheimer's disease (AD) biomarkers and cognitive function in two groups of...

Sponsor: Natalie DenburgEnrolling: 2301 location
RECRUITINGNCT06529744

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and...

To develop a model to predict disease progression in a large cohort of patients across a variety of neurodegenerative diseases, including Mild Cognitive Impairment (MCI) and...

Sponsor: University Health Network, TorontoEnrolling: 5004 locations
RECRUITINGNCT06703541

ADRC Clinical Cohort (Alzheimer's Disease)

The purpose of the study is to establish a clinical cohort for the Duke/UNC Alzheimer's Disease Research Center (ADRC). The cohort will be composed of subjects ages 25 to 44 at...

Sponsor: Duke UniversityEnrolling: 5001 location
RECRUITINGEarly Phase 1NCT05138848

Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease

Dementia caused by Alzheimer's disease affects approximately 5.6 million adults over age 65, with costs expected to rise from $307 billion to $1.5 trillion over the next 30 years....

Sponsor: University of PittsburghEnrolling: 1161 location
RECRUITINGNCT06561906

Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic,...

To establish the diagnostic and prognostic models that could help the preclinical identification of subjects at higher risk of clinical progression to mild cognitive impairment...

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolEnrolling: 10001 location
RECRUITINGNCT05877196

A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses

The goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible...

Sponsor: Arizona State UniversityEnrolling: 2161 location
RECRUITINGNCT05904132

Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease

The project is a placebo-controlled study that aims to use closed-loop transcranial alternating current stimulation (tACS) to study patients with symptoms of mild cognitive...

Sponsor: Massachusetts General HospitalEnrolling: 701 location
RECRUITINGPhase 2NCT04643327

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease

The present study is a proof-of-concept clinical trial to test the efficacy of low doses of a repurposed anti-epileptic drug (levetiracetam) in treating memory problems in...

Sponsor: The University of QueenslandEnrolling: 281 location
RECRUITINGPhase 1NCT04396873

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Background: About 5 million adults in the U.S. have Alzheimer s disease or another adult-onset neurodegenerative disorder. Many studies have found that inflammation in the brain...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 1841 location
RECRUITINGPhase 2NCT05446584

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

This study will probe if the biological changes in amnestic mild cognitive impairment (aMCI) are related to a history of mild traumatic brain injury (mTBI) using high definition...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 751 location
RECRUITINGNCT03233646

Retinal Imaging in Neurodegenerative Disease

This study aims to develop and evaluate biomarkers using non-invasive optical coherence tomography (OCT) and OCT angiography (OCTA) as well as ultra-widefield (UWF) fundus...

Sponsor: Duke UniversityEnrolling: 20001 location
RECRUITINGNCT06897670

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared...

The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional...

Sponsor: Mayo ClinicEnrolling: 2001 location
RECRUITINGNCT05858008

Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment

This study will investigate the feasibility of implementing a time-restricted eating intervention in females with mild cognitive impairment. Targeted therapeutic interventions...

Sponsor: Julie PendergastEnrolling: 151 location
RECRUITINGNCT06150352

Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment

Obstructive sleep apnea (OSA) is recurrent episodes of partial or complete obstruction of the upper airway during sleep that causes intermittent hypoxia and sleep fragmentation...

Sponsor: The University of Hong KongEnrolling: 1801 location
RECRUITINGNCT03761381

OCT Angiography and NRAI in Dementia

The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to: 1. Detect retinal blood vessel and blood flow changes in...

Sponsor: Oregon Health and Science UniversityEnrolling: 201 location
RECRUITINGNCT07402356

VR Pupillometry in Cognitive Impairment

With disease-modifying therapies emerging for dementia and related conditions, identifying cognitive decline as early as possible is increasingly important. This prospective,...

Sponsor: Max-Planck-Institute of PsychiatryEnrolling: 1401 location
RECRUITINGNCT03472664

Brain Energy for Amyloid Transformation in Alzheimer's Disease Study

The Brain Energy for Amyloid Transformation in AD (Alzheimer's disease) or BEAT-AD study will compare the effects of a ketogenic low-carbohydrate diet and a low-fat diet in adults...

Sponsor: Wake Forest University Health SciencesEnrolling: 1201 location